• Skip to primary navigation
  • Skip to content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Business Directory
    • Buyers | Licensees
    • Sellers | Ancillary Businesses
    • Submit Product & Service Press Release
  • CBE Exchange
  • CBE Jobs Exchange
  • Events
  • Featured Videos
  • Product & Service Press Releases
  • Sponsored Polls
  • Webinars
    • Upcoming Webinars
    • Archived Webinars
  • Whitepapers

Cannabis Business Executive - Cannabis and Marijuana industry news

Recreational, Medical, Marijuana, Cannabis, And Hemp News for Cannabis Businesses

  • Follow on Facebook
  • Follow on Twitter
  • Follow on Google+
  • Follow on LinkedIn
  • Subscribe to our RSS feed
Newsletter 2
  • Home
  • Policy & Legal
    • Hemp Business Executive
    • International
      • Canada
      • Mexico
      • Israel
    • US A to F
      • Alabama
      • Alaska
      • Arizona
      • Arkansas
      • California
      • Colorado
      • Connecticut
      • Delaware
      • District of Columbia
      • Florida
    • US G to M
      • Georgia
      • Hawaii
      • Illinois
      • Indiana
      • Idaho
      • Iowa
      • Kansas
      • Kentucky
      • Louisiana
      • Maine
      • Maryland
      • Massachusetts
    • US M to N
      • Michigan
      • Minnesota
      • Mississippi
      • Missouri
      • Montana
      • Nebraska
      • Nevada
      • New Hampshire
      • New Jersey
      • New Mexico
      • New York
      • North Carolina
      • North Dakota
    • US O to V
      • Ohio
      • Oklahoma
      • Oregon
      • Pennsylvania
      • Rhode Island
      • South Carolina
      • South Dakota
      • Tennessee
      • Texas
      • Utah
      • Vermont
    • US V to W
      • Virginia
      • Washington
      • Wisconsin
      • Wyoming
      • Guam
      • Puerto Rico
  • Industry News
    • Advertising, Marketing, PR & Research
    • Banking, Finance & Real Estate
    • Compliance and Regulations
    • Corporate Social Responsibility
    • Retailers
    • Hemp Business Executive
    • HR and Staffing
    • North Of The Border
    • Industry People/On the Move
    • Packaging and Supplies
    • Press Releases
    • Processors
    • Producers
    • Security Solutions
    • Science and Technology
    • South Of The Border
  • CBE Lists
    • Ancillary Businesses
      • 2019 CBE Ancillary Business Survey CLICK HERE
      • 2018 CBE 155 A/B
      • 2017 CBE 150 A/B
      • 2016 CBE 100 A/B
    • Producers, Processors, Retailers
      • 2017 CBE 200 PPRs
      • 2015 CBE 100 PPRs
    • Industry Women
      • Glass Ceiling Wreckers: 2019 CBE Power Women of Cannabis
      • 2017 CBE 75 Most Important Women
      • 2016 CBE Top 50 Women
      • 2014 CBE Most Influential Women
    • Most Important Companies
      • 2016 CBE 10 Most Important Companies
      • 2014 CBE 10 Most Important Companies
    • Political 100
      • 2017 CBE Political 100
      • 2016 CBE 100 Political
      • 2014 CBE Political 50
    • 2014 CBE 100 Most Important People
    • CBE RFP Hotlists
      • 2014 CBE Lab Testing Services HotList
      • 2016 BHO Extraction Equipment
      • 2016 CBE Supercritical CO2 Extraction Equipment
      • 2016 CBE Security Solutions
      • 2016 Edibles & Infused Products
  • Company Stories
    • Up and Comers
  • Hemp Business Executive
    • Hemp Policy & Legal
    • Hemp Industry News
    • Hemp State Regulatory Agencies
  • Newsletters
    • CBE Week
    • CBE Human Capital Management
    • CBE Technology & Solutions
    • CBE Policy and Legal Update
    • CBE Product and Service Announcements
  • Op-Ed
    • Cartoons
    • The Buck Stops Here
    • Opinions
    • Comments
  • Associations
  • State Regulatory Agencies
    • Marijuana
    • Hemp
  • Contact
  • AB Survey
  • About Us
  • Account
  • Accounting Services
  • Advertise
  • Advertising, PR & Marketing
  • All Cannabis News
  • Ancillary Business Survey 2018
  • Ancillary Business Survey 2019
  • Archived Webinars
  • Associations & Organizations
  • Banking & Payment Processing
  • Better Start for the Glass Ceiling in this Industry, CBE’s Most Influential Women
  • Book Reviews
  • Business Directory
  • Business Directory Introduction
  • Business Directory Listing
  • Business Directory Manage
  • Business Directory Registration Info
  • Business Directory Welcome
  • Call for speakers
  • Cannabis Investments
  • Cart
  • CBE Exchange
  • CBE HotLists
    • CBE Lab Testing Services HotList 2014
  • CBE Lists
  • CBE Political 50
  • CBE Press LLC Privacy Statement
  • CBE Press News
  • Checkout
  • Consulting Services
  • Consumption Gear
  • Contact
  • Contribute
  • Contributors
  • Create Your Product & Service Press Release
  • Creative Submission
  • Cultivation Products & Services
  • Current Poll
  • Edible & Infused Products
  • Editor’s Page
  • Email Whitelisting Instructions
  • Event Listing Questionaire
  • Featured Videos
  • Funding Options
  • Hemp State Regulatory List
  • Home
  • Human Capital Management Newsletters
  • Industry Jobs
  • Join the CBE Business Directory
  • Join the Directory
  • Lab Testing Regulations
  • Lab Testing Services
  • Login
  • Logout
  • Marijuana State Regulatory Contacts
  • Marijuana Tax Facts
  • Media Kit
  • Medical Marijuana Qualifying Conditions
  • Members
  • MJ Media Kit
  • Most Popular Stories
  • Most Read Stories
  • New Product & Service Listings Welcome
  • News Releases
  • Newsletters
    • Ask CBE
    • CBE Human Capital Management
    • CBE Policy and Legal Update
    • CBE Product and Service Announcements
    • CBE Technology & Solutions
    • CBE Week
  • On the Move
  • Organizations & Associations
  • Packaging & Supplies
  • Password Reset
  • Policy & Legal
  • PPR Survey
  • Product Releases
  • Profile Update
  • Register
  • Security Solutions
  • Software & Technology
  • Sponsored Polls
  • State Cannabis Product Packaging Requirements
  • Terms of Service
  • Thank You
  • The Most Influential People in the Cannabis Industry, The Cannabis Business Executive 100
  • Training & Educational Services
  • Upcoming Webinars
  • User
  • Whitepapers
  • WV Senate passes medical marijuana bill to House
  • Categories
  • Locations
  • My Bookings
You are here: Home / Industry News / Medical Marijuana / Huge Rise In UK Medical Cannabis Imports As Private Sector Steps-Up To Meet Patient Demand

Huge Rise In UK Medical Cannabis Imports As Private Sector Steps-Up To Meet Patient Demand

January 4, 2021 by Peter McCusker Leave a Comment

NEW Government figures show a 900% increase in the number of cannabis medicines notified for import demonstrating the private sector’s growing role in fulfilling UK demand.

Between March 1, and October 1, this year, the number of packs of unlicensed CBPMs (cannabis-based products for medicinal use) notified for import was 37,543, up from 3,741 in the previous 16 months.

Whilst, not all of these will have been actioned – and will be a function of a regulatory change to allow for bulk imports – it tallies with suggestions the number of private UK patients is now up to around 2,500.

The findings were published at the weekend in a report by the Advisory Council For the Misuse of Drugs (ACMD), in a mandated review into the effectiveness of the UK medical cannabis regime.

Less Than Five Patients Through NHS

In a covering letter to Home Secretary Priti Patel, dated November 27, Professor Owen Bowden-Jones, Chair of ACMD, highlights how less than five patients have been prescribed unlicensed CBPMs.

The report highlights how 800 patients a year received the UK’s three licensed cannabis products; Epidyolex, Nabilone and Sativex between 2017 and 2019, and says that number is now increasing.

It goes on to say that up to 224 private patients may have been treated with unlicensed CBPMs, whilst also highlighting concerns over the reliability of some of its data.

Industry experts approached by BusinessCann believe the number of private patients is somewhere between 1,500 and 2,500.

Pierre van Weperen, Managing Director, Grow Biotech, and CEO, Grow Pharma, put the number at 1,500. He said: “We have seen good growth recently due to a combination of factors including more prescribing doctors, initiatives such Open Cannabis, and a stable supply chain, which has helped cut prices.”

Speaking at the Prohibition Partners Live earlier this month Jonathan Nadler, Managing Director of the Lyphe Group, which runs the Medical Cannabis Clinics, said it has 1,000 patients on its books and it believes there are a further 1,000 being prescribed by the UK’s other private clinics.

Technology entrepreneur Gavin Sathianathan, founder of Alta Flora, the creators of Eva – a patient data app – highlights the flaws in the collection of private prescription data, acknowledged by the report’s authors.

“I believe they have extrapolated data they had until February 20 – before Covid-19 – which does not take into account the recent growth in the market especially due to the launch of Project Twenty21 and the relaxation of the import restrictions in March,” he said.

He believes there are now nearly 2,500 patients receiving prescriptions through private clinics with some 200 enrolled on Drug Science’s Project Twenty21.

The ACMD report entitled ‘Cannabis-based products for medicinal use (CBPMs) in humans’  found that the number of unlicensed CBPMs available has now risen from four, at the time of the 2018 law change, to 29. 

Patient Registry, Further Research

BusinessCann has reported previously how the private sector is stepping up to meet demand and one of the country’s largest suppliers Grow Pharma has a portfolio of over 20 medicines.

The report also looks into the lack of prescribing through the NHS saying:

  • There is a lack of safety and efficacy data for many unlicensed CBPMs
  • Prescribing unlicensed CBPMs is limited only to specialists on the register of the General Medical Council
  • The relatively high costs of unlicensed medicines – although the latest data shows these medicines are at least half the price of 12 months ago

It goes on to say that the increase in the prescribing of licensed cannabis medicines followed the publication of NICE guidance on ‘cannabis-based medicinal products’ and the granting of marketing authorisation for Epidyolex in the UK.

The report says progress is being made in establishing an NHS cannabis patent patient registry, and says there ‘has been little interest from manufactures of unlicensed CBPM to apply for regulatory approval’.

It goes on to say there has been an insufficient period of time to determine whether CBPMs have impacted on the prevalence of illicit cannabis use.

It recommends a further review in a couple of years and the need for further research.

Reprinted with the permission of BusinessCann

Filed Under: Medical Marijuana Tagged With: Medical Cannabis Imports, medical marijuana patients, United Kingdom

About Peter McCusker

Peter McCusker is the Founder and Editor of BusinessCann and an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant. BusinessCann covers the ins and outs of the growing European Regulated Medical Marijuana marketplace. Peter can be reached at [email protected].

BusinessCann is an online news publication, which supports the growth of Europe’s Hemp, CBD and Medicinal Cannabis industries by providing factual and feature articles, comment and profiles on the people and businesses forging its growth and development.

Primary Sidebar

Ad: Sidebar 1

Featured Video

Associations & Organizations

clearing div

Ad: Sidebar 2

Business Directory

Ad: Skyscraper 1

CBE Jobs Exchange


Featured Jobs
Go
Post a Job
More jobs
Powered by CBEJobsExchange.com

RSS Recent Jobs

  • Business Development Officer - Specialty Ag - Bank Michigan - Ann Arbor, MI
  • Field Applications Support Scientist - Danaher - Framingham, MA
  • Flash Chromatography Applications Chemist - VRS Recruitment - , NY

Product & Service Press Releases

Ad: Sidebar 3

CBE Events

Ad: Sidebar 4

State Regulatory Agencies

Ad: Skyscraper 2

Webinars

Ad: Sidebar 5

Associations & Organizations

Ad: Sidebar 6

Featured Video

Ad: Skyscraper 3

Business Directory

Ad: Sidebar 7

CBE Jobs Exchange

Ad: Sidebar 8

CBE Events

Ad: Skyscraper 4

Industry Blogs



Footer

  • Home
  • About Us
  • Advertise
  • Contact
  • CBE Press LLC Privacy Statement
  • Contribute
  • Contributors
  • Newsletters
  • Terms of Service
  • Contributor Login
  • Follow on Facebook
  • Follow on Twitter
  • Follow on Google+
  • Follow on LinkedIn
  • Subscribe to our RSS feed
Newsletter 2

© Copyright 2020 CBE PRESS LLC. - All Rights Reserved. Cannabis Business Executive Is A Trademark Of CBE PRESS LLC. · All Rights Reserved · And Our Sitemap · All Logos & Trademarks Belong To Their Respective Owners·